StonvexLoading…
StonvexStonvexStonvexCore line items from XELB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.94M | $8.26M | $17.75M | $25.78M |
Operating Income | $-13.23M | $-21.41M | $-20.64M | $-2.26M |
Net Income | $-17.46M | $-22.39M | $-21.05M | $-4.02M |
EPS (Diluted) | $-5.08 | $-9.84 | $-10.68 | $-0.20 |
Total Assets | $38.95M | $53.76M | $71.66M | $88.94M |
Total Liabilities | $23.12M | $25.36M | $23.49M | $18.80M |
Cash & Equivalents | $1.15M | $1.25M | $3.00M | $4.61M |
Free Cash Flow OCF − CapEx | $-7.03M | $-4.83M | $-6.64M | $-14.45M |
Shares Outstanding | 5.88M | 2.37M | 1.98M | 19.62M |